The fourteen members of the Committee are acknowledged experts from around the world in the fields of epidemiology, statistics, paediatrics, internal medicine, pharmacology and toxicology, infectious diseases, public health, immunology and autoimmunity, drug regulation and safety. The members currently work for, or have retired from, organizations such as governmental agencies, public health institutes, drug regulation agencies, medical research institutes and universities. Their involvement in the Committee is, however, strictly in their individual capacities.
Members are appointed by the Director of the WHO Department of Essential Medicines and Health Products (EMP).
The impartiality and high level of expertise represented ensures that the recommendations put forward by the Committee are made in an independent manner and with scientific rigour.
Given the sensitive nature of the issues discussed at the twice-yearly Committee meetings, ensuring that members participate in Committee deliberations in a completely independent and unbiased manner is critical. To this end, prior to each meeting, members must declare any potential conflict of interest and sign a confidentiality agreement.